Publication | Open Access

Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial

Satralizumab MonotherapyPlacebo-controlled Phase 3OphthalmologyMedicineNeurologyMultiple SclerosisNeuroimmunology